Signati Medical Announces Completion of Enrollment in First-in-Human Clinical Trial for Groundbreaking Sealed Vasectomy Procedure
18 juil. 2024 11h17 HE
|
Signati Medical Inc.
Providence, RI, July 18, 2024 (GLOBE NEWSWIRE) -- Signati Medical™, a medical device company dedicated to advancing men’s health, today announced the successful completion of enrollment in its...
Signati™ Medical Enrolls First Patient in Groundbreaking Sealed Vasectomy Procedure Trial
18 juil. 2024 09h00 HE
|
Signati Medical Inc.
Providence, RI, July 18, 2024 (GLOBE NEWSWIRE) -- Signati Medical™, a medical device company dedicated to advancing men’s health, today announced the successful completion of enrollment in its...
Signati™ Medical Enrolls First Patient in Groundbreaking Sealed Vasectomy Procedure Trial
09 avr. 2024 09h00 HE
|
Signati Medical Inc.
Providence, RI, April 09, 2024 (GLOBE NEWSWIRE) -- Signati™ Medical, a medical device company dedicated to advancing men’s health, today announced the successful enrollment of the first patient in...
Signati™ Medical, Inc. Announces Board Member Dr. Jones Joins Urology Austin
12 févr. 2024 09h00 HE
|
Signati Medical Inc.
Providence, RI, Feb. 12, 2024 (GLOBE NEWSWIRE) -- LeRoy Jones, MD, Board-Certified Urologist and Signati™ Medical, Inc. Board Member, starts a new chapter in his career at Urology Austin. Dr. Jones...
Signati™ Medical, Inc. Receives FDA Approval for IDE Study
20 déc. 2023 09h00 HE
|
Signati Medical Inc.
Providence, RI, Dec. 20, 2023 (GLOBE NEWSWIRE) -- The FDA has officially approved Signati™ Medical’s Investigational Device Exemption (IDE) study! This comes on the company’s 5 year anniversary....
Signati Medical™ Receives Additional Patent Protection for its Innovative Bipolar Handpiece
28 sept. 2023 09h00 HE
|
Signati Medical Inc.
Providence, RI, Sept. 28, 2023 (GLOBE NEWSWIRE) -- Signati Medical™ is pleased to announce the issue of US patent 11,723,680 covering critical features of the bipolar handpiece used in Signati’s...
Signati™ Medical Files IDE Study with FDA
26 sept. 2023 09h00 HE
|
Signati Medical Inc.
Providence, RI, Sept. 26, 2023 (GLOBE NEWSWIRE) -- Signati™ Medical has officially filed their IDE study with the FDA. An Investigational Device Exemption (IDE) allows the investigational device to...
Signati™️ Medical, Inc. Announces Dr. LeRoy Jones Has Been Appointed to Its Board of Directors
03 août 2023 09h00 HE
|
Signati Medical Inc.
Providence, RI, Aug. 03, 2023 (GLOBE NEWSWIRE) -- Signati™️ Medical, Inc. announced today that Dr. LeRoy Jones has been appointed to its Board of Directors. Dr. Jones is considered an authority in...
Signati™ Medical, Inc. Completes Acquisition of SuperiorVAS Intellectual Property and Technology
09 déc. 2022 09h00 HE
|
Signati Medical Inc.
Providence, RI, Dec. 09, 2022 (GLOBE NEWSWIRE) -- Signati™ Medical, Inc. today announced that it has completed the acquisition of all of the intellectual property and technology of SuperiorVAS, LLC,...
Signati™ Medical, Inc. Debuts Innovative Bipolar Radio Frequency Sealing Platform at American Urological Association (AUA) Annual Meeting
24 mai 2022 09h00 HE
|
Signati Medical Inc.
Providence, RI, May 24, 2022 (GLOBE NEWSWIRE) -- Signati™ Medical, Inc. is pleased to announce the unveiling of their innovative Sealed Vasectomy Procedure at this year’s AUA Annual Meeting in New...